An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor
- 24 September 2010
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 28 (41), 6740-6748
- https://doi.org/10.1016/j.vaccine.2010.07.075
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- The early humoral immune response toBacillus anthracistoxins in patients infected with cutaneous anthraxFEMS Immunology & Medical Microbiology, 2011
- Follicular helper T cells as cognate regulators of B cell immunityCurrent Opinion in Immunology, 2009
- Frequency and Domain Specificity of Toxin-Neutralizing Paratopes in the Human Antibody Response to Anthrax Vaccine AdsorbedInfection and Immunity, 2009
- Sequential B-Cell Epitopes ofBacillus anthracisLethal Factor Bind Lethal Toxin-Neutralizing AntibodiesInfection and Immunity, 2009
- Towards a human oral vaccine for anthrax: The utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategyVaccine, 2008
- Activity of the Bacillus anthracis20 kDa protective antigen componentBMC Infectious Diseases, 2008
- Domain specificity of the human antibody response to Bacillus anthracis protective antigenVaccine, 2008
- Human Monoclonal Antibodies against Anthrax Lethal Factor and Protective Antigen Act Independently To Protect againstBacillus anthracisInfection and Enhance Endogenous Immunity to AnthraxInfection and Immunity, 2007
- Oral Administration of a Salmonella enterica -Based Vaccine Expressing Bacillus anthracis Protective Antigen Confers Protection against Aerosolized B. anthracisInfection and Immunity, 2007
- Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen ofYersinia pestisusing novel delivery vehiclesFEMS Immunology & Medical Microbiology, 2003